US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, presented early-stage cost-effectiveness analysis of its ...
Derren Brown: Incognito (WT) is a new six-part series from Channel 4, Vaudeville Productions and the mind of Derren Brown. We all make snap judgements about people, built on years of social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results